Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Potassium Iodide

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 72Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vitalah® Announces Three Changes to Adult Oxylent® Formula
    Vitalah® Announces Three Changes to Adult Oxylent® Formula

    03 Nov 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/vitalah-announces-three-changes-to-adult-oxylent-formula-300356996.html

    PR NEWSWIRE
    03 Nov 2016
    Share Share
    Mission Pharmacal Receives FDA Approval for Liquid Potassium Iodide Oral Sol
    Mission Pharmacal Receives FDA Approval for Liquid Potassium Iodide Oral Sol

    17 May 2016

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mission-pharmacal-receives-fda-approval-for-liquid-potassium-iodide-oral-solution-for-nuclear-emergency-management-300270047.html

    PR NEWSWIRE
    17 May 2016
    Share Share
    Mission Pharmacal's Generic Potassium Iodide approved in US to treat Hyperthyroidism
    Mission Pharmacal's Generic Potassium Iodide approved in US to treat Hyperthyroidism

    24 Mar 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/mission-pharmacals-generic-potassium-iodide-approved-in-us-to-treat-hyperthyroidism-1459159935.pdf

    FDA
    24 Mar 2016
    Share Share